{
    "organizations": [],
    "uuid": "e2e0549f5d0fd78c6c4cbe2fa8db44bb8f46aa6b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-quantum-genomics-fy-net-loss-widen/brief-quantum-genomics-fy-net-loss-widens-to-9-4-million-euros-idUSFWN1RB0XZ",
    "ord_in_thread": 0,
    "title": "Quantum Genomics FY Net Loss Widens To 9.4 Million Euros",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - QUANTUM GENOMICS SA:\n* ON 31 DECEMBER 2017, OPERATING INCOME WAS -EUR10.3 MILLION, COMPARED WITH -EUR6.2 MILLION ONE YEAR EARLIER\n* AT END-DEC., THERE WAS €8.9 MILLION IN EQUITY CAPITAL AND €11.1 MILLION IN AVAILABLE CASH FLOW\n* FY NET LOSS EUR 9.4‍​ MILLION VERSUS LOSS OF EUR 5.2 MILLION YEAR AGO\n* REPORTS FOR H1 A NET INCOME OF -EUR9.4 MILLION VERSUS -EUR5.2 MILLION FOR FIRST HALF OF 2016 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-30T00:37:00.000+03:00",
    "crawled": "2018-03-30T13:31:24.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "quantum",
        "genomics",
        "sa",
        "december",
        "operating",
        "income",
        "million",
        "compared",
        "million",
        "one",
        "year",
        "earlier",
        "million",
        "equity",
        "capital",
        "million",
        "available",
        "cash",
        "flow",
        "fy",
        "net",
        "loss",
        "eur",
        "million",
        "versus",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "report",
        "h1",
        "net",
        "income",
        "million",
        "versus",
        "million",
        "first",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}